CNO raises guidance as Medicare Supplement sales surge higher
- CNO is refocusing on core insurance after exiting a weak Worksite fee services business.
- Management raised full-year 2026 operating EPS guidance to a range of $4.60 to $4.80 after strong first-half results.
- A consumer shift toward Medicare Supplement plans drove a 52 percent jump in new sales for that product line in the second quarter.
- Health is the largest insurance line, accounting for over half of total insurance product margins.
- The main risks are investment losses, interest rate swings, and health claims that cost more than priced.
A cleaner insurance story with raised targets
CNO's story has become simpler and more profitable. The company left the Worksite fee services business to put more focus on health, annuity, and life insurance. That matters because management expects the exit to cut annual fee revenue by about $30 million but lift annual pre-tax income by about $20 million.
The latest proof point arrived in the second quarter of 2026. Management raised its full-year operating EPS guidance to a range of $4.60 to $4.80 after posting $1.26 per share in the quarter, up 45 percent from a year earlier. A major driver is Medicare Supplement sales, which grew 52 percent as consumers shifted away from Medicare Advantage plans.
The bull case is about clean execution and structural growth. If the Medicare Supplement trend holds, CNO's largest segment has a clear path for expansion. The company also continues to buy back shares with its excess cash, rewarding shareholders as profitability improves.
The bear case points to near-term bumps and long-term liabilities. Direct-to-consumer life sales recently fell 9 percent as CNO changed its marketing strategy from television to digital channels. Beyond sales, this is an insurer with long promises. Investment markets, credit losses, interest rates, and health care costs can all move against the company.
Premiums, claims, and investments
CNO makes money in three main ways. It collects premiums and tries to price policies so claims and expenses leave a profit. It earns investment income on the money it holds before paying claims. It also earns fees from services and from selling some third-party products.
The company targets middle-income Americans who are near retirement or already retired. Its reach comes from exclusive agents, independent producers, direct-to-consumer channels, phone, virtual, online, and face-to-face sales.
This model can work well when pricing is right and policyholders stay with the company. It can break when claims run hotter than expected, policyholders leave at bad times, or the investment portfolio loses value.
Products for older households
Health insurance
This is CNO's largest product line by insurance product margin. It includes supplemental health, Medicare Supplement, and long-term care products.
Medicare Supplement
This product helps cover costs that original Medicare does not cover. It recently saw 52 percent sales growth as consumers shifted away from Medicare Advantage plans.
Long-term care
Long-term care can be profitable when claims and rate increases behave well. It is also one of the hardest products to price because claims can last for years.
Annuities
CNO mainly sells fixed indexed and fixed interest annuities. These products turn savings into more predictable income, but results are sensitive to interest rates and investment returns.
Life insurance
The Life line includes interest-sensitive and traditional life products. It adds scale and steady margin, but depends on mortality, lapses, and investment spreads.
Third-party Medicare Advantage sales
The remaining Fee Income segment mainly comes from selling third-party Medicare Advantage products. It provides incremental revenue but requires careful tracking of revenue recognition.
Health leads the mix
The segment mix below uses Q1 2026 insurance product margin of $256.9 million. It excludes investment income not allocated to products and the remaining Fee Income segment.
What could go wrong
Claims cost more than priced
High impact · Medium oddsCNO's profit depends on mortality, morbidity, health care costs, and policyholder behavior. Long-term care is a special risk because claims can be large and long-lasting. If the company cannot get needed rate increases on time, margins can fall.
Investment portfolio stress
High impact · Medium oddsCNO holds a large investment portfolio to support future insurance claims. Credit losses, market volatility, or weaker capital markets can hurt earnings and capital. This risk can show up even when policy sales look fine.
Interest rates move against the model
Medium impact · Medium oddsInterest rates affect annuity spreads, investment income, policyholder behavior, and the value of assets. Fast rate moves can pressure cash flow and product profitability. The direction matters less than whether pricing and investments can adjust fast enough.
Marketing channel disruption
Low impact · Medium oddsCNO is shifting its direct-to-consumer marketing away from television and toward digital channels. This transition caused a drop in direct life sales in the second quarter of 2026. If the new digital channels fail to convert, life sales could face prolonged pressure.
In one breath
What does CNO Financial Group do?
CNO sells health, annuity, and life insurance products. Its main customers are middle-income Americans who are near retirement or already retired.
Why is CNO exiting the Worksite fee services business?
Management says the exit sharpens focus on the core insurance business. The company expects the move to reduce annual fee revenue by about $30 million but increase annual pre-tax income by about $20 million.
What is the most important CNO segment?
Health is the largest insurance product line by product margin. It includes supplemental health, Medicare Supplement, and long-term care products.
What should investors watch next?
The key items are progress toward the newly raised 2026 operating EPS guidance, Medicare Supplement sales momentum, and the stabilization of direct-to-consumer life sales.
Sources and research notes
This page combines Finn's company research with public filings and other cited materials. The thesis is reviewed when material company information changes; Finn Scores use the latest available scoring data.
- Thesis reviewed
- August 23, 2026
- Score data
- September 6, 2026
- Reviewed by
- Shivam Bharuka
Comparable Insurance - Life companies
Companies near CNO Financial Group, Inc. in Finn's Insurance - Life industry ranking.
